Sabrina Fabbri

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia.

An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia.

Journal: Muscle & nerve
Published: November 11, 2020

Meralgia Paraesthetica after Prone Position Ventilation in a Patient with COVID-19.

Meralgia Paraesthetica after Prone Position Ventilation in a Patient with COVID-19.

Journal: European journal of case reports in internal medicine
Published: October 03, 2020

Tailoring B cell depletion therapy in MS according to memory B cell monitoring.

Tailoring B cell depletion therapy in MS according to memory B cell monitoring.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 20, 2020

A novel mutation of Twinkle in Perrault syndrome: A not rare diagnosis?

A novel mutation of Twinkle in Perrault syndrome: A not rare diagnosis?

Journal: Annals of human genetics
Published: November 21, 2019

Ghost spasticity in multiple sclerosis.

Ghost spasticity in multiple sclerosis.

Journal: Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology
Published: September 18, 2019

A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy.

A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy.

Journal: Journal of the neurological sciences
Published: October 26, 2018

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".

Journal: Orphanet journal of rare diseases
Published: July 20, 2018

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 23, 2017

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Journal: Journal of the peripheral nervous system : JPNS
Published: January 21, 2014

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 22, 2013

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 11, 2013

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 23, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026